Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Novartis
Marengo Therapeutics, Inc.
Xencor, Inc.
University of Wisconsin, Madison
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)